Search results for "real-world intervention"

showing 2 items of 2 documents

ReMindCare App for Early Psychosis: Pragmatic Real World Intervention and Usability Study

2020

[EN] Background: eHealth interventions are widely used in clinical trials and increasingly in care settings as well; however, their efficacy in real-world contexts remains unknown. ReMindCare is a smartphone app that has been systematically implemented in a first episode of psychosis program (FEPP) for patients with early psychosis since 2018. Objective: The objective of this study was to assess the efficacy of ReMindCare after 19 months of use in the clinic and varying use by individual patients. Methods: The integration of the ReMindCare app into the FEPP started in October 2018. Patients with early psychosis self-selected to the app (ReMindCare group) or treatment as usual (TAU group). T…

AdultMaleTelemedicine020205 medical informaticsEuropean Regional Development FundHealth Informatics02 engineering and technologyClinical practiceReal-world intervention03 medical and health sciences0302 clinical medicineNursingIntervention (counseling)Political science0202 electrical engineering electronic engineering information engineeringAmbulatory CareCIENCIAS DE LA COMPUTACION E INTELIGENCIA ARTIFICIALmedia_common.cataloged_instanceHumansPsiquiatriaEuropean unionSalut mentalmedia_commonOriginal Paperbusiness.industryEarly psychosisUsabilityPsychosisMental healthMobile ApplicationsTelemedicine030227 psychiatryClinical PracticePsychotic DisordersFemaleMental healthSmartphonebusinessApp
researchProduct

ReMindCare App for Early Psychosis: Pragmatic Real World Intervention and Usability Study

2020

Background: eHealth interventions are widely used in clinical trials and increasingly in care settings as well; however, their efficacy in real-world contexts remains unknown. ReMindCare is a smartphone app that has been systematically implemented in a first episode of psychosis program (FEPP) for patients with early psychosis since 2018. Objective: The objective of this study was to assess the efficacy of ReMindCare after 19 months of use in the clinic and varying use by individual patients. Methods: The integration of the ReMindCare app into the FEPP started in October 2018. Patients with early psychosis self-selected to the app (ReMindCare group) or treatment as usual (TAU group). The ou…

real-world interventionpsychosistelemedicineappmental healthclinical practice
researchProduct